Photodynamic and Cytotoxic Evaluation of Euphorbia anacampseros Methanolic Extract: Chemical Characterization, Molecular Docking, and Light‐Activated Anticancer Activity
Chemistry & Biodiversity · 2026-11 · 23 (11)
DOI: 10.1002/cbdv.71897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 30.10.2026. Verfasst von Sercin Ozlem Caliskan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Biophysics, Usak University, Usak, Türkiye. Hauptthemen laut MEDLINE: Euphorbia, Molecular Docking Simulation, Plant Extracts, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed to characterize the chemical constituents of the methanolic extract of Euphorbia anacampseros using high‐performance liquid chromatography (HPLC–DAD) and gas chromatography–mass spectrometry (GC–MS) analyses. The cytotoxic activity of the extract was assessed using the MTT assay, and its light‐enhanced cytotoxic effects were evaluated to investigate its potential for future photodynamic applications. Additionally, molecular docking analysis was performed to evaluate interactions between the identified compounds and the porphobilinogen deaminase (PBGD) enzyme. The mean inhibitory concentration (IC 50 ) values were 54.72 µg/mL for HT‐29, 50.34 µg/mL for MCF‐7, and 58.97 µg/mL for A549 cell lines. In the dark, the extract exhibited moderate and nonselective baseline cytotoxicity across all tested cell lines, with IC 50 values ranging from 46.95 to 58.97 µg/mL. However, the cytotoxic activity of the extract in HT‐29 cells was significantly enhanced following irradiation with blue, green, yellow, or red light, suggesting its potential for future photodynamic applications. Molecular docking targeting PBGD revealed that rutin and epicatechin exhibited the highest binding affinities, with binding energies of –9.9 and –7.8 kcal/mol, respectively. These findings suggest that E. anacampseros constituents may act as photosensitizing agents, potentially enhancing photodynamic therapy through interactions with enzymes involved in porphyrin metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Biophysics, Usak University, Usak, Türkiye.
- Faculty of Medicine, Department of Medical Biology, Usak University, Usak, Türkiye.
- Faculty of Medicine, Department of Medical Biochemistry, Necmettin Erbakan University, Konya, Türkiye.
- Medicinal-Aromatic Plants Application and Research Center, Artvin Çoruh University, Artvin, Türkiye.
- Meram Vocational School Konya, Necmettin Erbakan University, Konya, Türkiye.
- Medical and Cosmetic Plants Application and Research Center, Konya, Türkiye.
ORCID-Profile: Sercin Ozlem Caliskan, Metin Caliskan, Emine İncilay Torunoğlu, Abidin Gümrükçüoğlu, Erdi Can Aytar
Zitieren
APA
Caliskan, S. O., Caliskan, M., Torunoğlu, E. İ., Gümrükçüoğlu, A., Doğu, S., & Aytar, E. C. (2026). Photodynamic and Cytotoxic Evaluation of Euphorbia anacampseros Methanolic Extract: Chemical Characterization, Molecular Docking, and Light‐Activated Anticancer Activity. Chemistry & Biodiversity, 23(11). https://doi.org/10.1002/cbdv.71897
Vancouver
Caliskan SO, Caliskan M, Torunoğlu Eİ, Gümrükçüoğlu A, Doğu S, Aytar EC. Photodynamic and Cytotoxic Evaluation of Euphorbia anacampseros Methanolic Extract: Chemical Characterization, Molecular Docking, and Light‐Activated Anticancer Activity. Chemistry & Biodiversity. 2026;23(11). doi:10.1002/cbdv.71897
BibTeX
@article{Caliskan2026,
author = {Caliskan, Sercin Ozlem and Caliskan, Metin and Torunoğlu, Emine İncilay and Gümrükçüoğlu, Abidin and Doğu, Süleyman and Aytar, Erdi Can},
title = {Photodynamic and Cytotoxic Evaluation of Euphorbia anacampseros Methanolic Extract: Chemical Characterization, Molecular Docking, and Light‐Activated Anticancer Activity},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {11},
doi = {10.1002/cbdv.71897}
}
EUVIMED